Companion Animal Diagnostics Market worth $3.8 billion by 2027 - Exclusive Report by MarketsandMarkets™

News provided by

29 Apr, 2022, 12:30 GMT

CHICAGO, April 29, 2022 /PRNewswire/ -- According to the new market research report "Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Molecular Diagnostics, Hematology), Application (Clinical Pathology, Bacteriology, Virology), Animal, End User (Diagnostics Labs, Clinics) - Global Forecast to 2027", published by MarketsandMarkets™, the Companion Animal Diagnostics Market is projected to reach USD 3.8 billion by 2027 from USD 2.4 billion in 2022 at a CAGR of 9.6% during the forecast period.

Browse in-depth TOC on "Companion Animal Diagnostics Market"
433 – Tables
49 – Figures
392 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173823870

The growth in this market is driven by the increasing companion animal population, rising adoption of pet insurance, growing animal health expenditure, and the increasing number of veterinary practitioners & their rising income level in developed countries. The growing usage and demand for rapid tests and portable instruments for point-of-care (POC) services is offering new growth opportunities for companies in the market. On the other hand, a lack of animal health awareness and a shortage of veterinarians in emerging markets pose significant challenges in the market.

In this report, the companion animal diagnostics market has been segmented on the basis of technology, application, animal type, end user, and region.

"Molecular diagnostics is expected to witness the fastest growth companion animal diagnostics market during the forecast period."

Based on technology, the companion animal diagnostic market is segmented into clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics, and other companion animal diagnostic technologies. The molecular diagnostics segment is projected to register the highest CAGR during the forecast period. The high growth rate of this segment can be attributed to the results of the quick and reliable diagnostics.

"Clinical Pathology segment is expected to witness the fastest growth in the forecast period."

Based on application, the companion animal diagnostics market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. Clinical pathology includes all primary diagnostic tests that utilize blood and other body fluids for efficient and accurate disease diagnosis and screening of animal health. In 2021, clinical pathology was the largest application segment in this market. One of the major factors driving the growth of this application segment is the high volume of clinical pathology tests performed on companion animals. This is because clinical pathology tests are recommended by veterinarians to evaluate the cause of diseases (in the case of chronic conditions) in companion animals.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173823870

"Dog segment accounted for the largest share of by animal type of companion animal diagnostics market in 2021"

Based on animal type, the companion animal diagnostic market is segmented into dogs, cats, horses, and other companion animals. Companion animal diagnostics for dogs accounted for the largest share of this market in 2021. The large share and high growth in this segment is attributed to factors such as the increasing dog population and ownership rate, the rising canine healthcare expenditure, and the increasing number of pet insurers across the globe.

"Asia Pacific region is expected to witness the fastest growth during the forecast period"

On the basis of region, the companion animal diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is projected to grow at a highest growth rate during the forecast period. Factors such as the rapidly increasing animal population, growing awareness about animal welfare, and the rising prevalence of zoonotic diseases are driving the growth of this regional market.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=173823870

Key Market Players:

Key players in this companion animal diagnostics market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Some major players in this market are Idexx Laboratories, INC. (US), Zoetis, INC. (US), Heska Corporation (US), Thermo Fisher Scientific, INC. (US), Biomérieux SA (France), Virbac (France), Neogen Corporation (US), Fujifilm Holdings Corporation (Japan), Indical Bioscience GmbH (Germany), Idvet (France), Randox Laboratories, LTD. (UK), Shenzhen Mindray Animal Medical Technology Co., Ltd. (China), and BioNote, Inc (South Korea).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User, Region-Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/veterinary-poc-diagnostics-market-105329994.html

Veterinary Diagnostics Market by Product(Instruments, Consumables), Technology (Immunodiagnostics (Lateral Flow, ELISA), Clinical Biochemistry, PCR, Hematology, Urinalysis), Animal (Dog, Cat, Cattle, Pig, Poultry, Horse), End User - Global Forecast to 2026 https://www.marketsandmarkets.com/Market-Reports/veterinary-diagnostics-market-26017452.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/companion-animal-diagnostic-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/companion-animal-diagnostic.asp